Antitumor Effect of Vaccinia Virus Double Recombinant Strains Expressing Genes of Cytokine GM-CSF and Oncotoxic Peptide Lactaptin
Authors:
Open Access
- 5 December 2017
- book chapter
- Published by Springer Nature
- p. 581-590
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Highly effective production of biologically active, secreted, human granulocyte-macrophage colony-stimulating factor by recombinant vaccinia virusApplied Biochemistry and Microbiology, 2016
- Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapyOncotarget, 2016
- Replicating poxviruses for human cancer therapyJournal of Microbiology, 2015
- Sensitivity of endometrial cancer cells from primary human tumor samples to new potential anticancer peptide lactaptinJournal of Cancer Research and Therapeutics, 2015
- Oncolytic PoxvirusesAnnual Review of Virology, 2014
- Lactaptin Induces p53-Independent Cell Death Associated with Features of Apoptosis and Autophagy and Delays Growth of Breast Cancer Cells in Mouse XenograftsPLOS ONE, 2014
- A novel pro-apoptotic effector lactaptin inhibits tumor growth in mice modelsBiochimie, 2012
- Oncolytic poxvirusesMolecular Genetics, Microbiology and Virology, 2012
- Analysis of biochemical markers of MCF-7 cell apoptosis induced by a recombinant analogue of lactaptinRussian Journal of Bioorganic Chemistry, 2012
- Recombinant Analogs of a Novel Milk Pro-Apoptotic Peptide, Lactaptin, and Their Effect on Cultured Human CellsThe Protein Journal, 2010